Measurement of Renal Function With Iohexol in Subjects Ingesting Carnitine

This study has been withdrawn prior to enrollment.
Sponsor:
Information provided by:
Montefiore Medical Center
ClinicalTrials.gov Identifier:
NCT01392313
First received: July 11, 2011
Last updated: NA
Last verified: July 2011
History: No changes posted
  Purpose

The investigators will measure renal function in subjects ingesting carnitine to determine if the product alters renal function.


Condition Intervention
Carnitine Ingestion
Dietary Supplement: Carnitine

Study Type: Interventional
Study Design: Endpoint Classification: Safety Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Measurement of Glomerular Filtration Rate (GFR) Using Iohexol in Healthy Subjects Taking Creatinine Supplements

Resource links provided by NLM:


Further study details as provided by Montefiore Medical Center:

Primary Outcome Measures:
  • Iohexol clearance [ Time Frame: 1 month ] [ Designated as safety issue: Yes ]
    Iohexol clearance will be measured


Estimated Enrollment: 5
Study Start Date: May 2010
Estimated Study Completion Date: June 2010
Estimated Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)
Intervention Details:
    Dietary Supplement: Carnitine
    Carnitine Ingestion
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • carnitine ingestion

Exclusion Criteria:

  • renal disease
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01392313

Locations
United States, New York
Montefiore Medical Center
Bronx, New York, United States, 10467
Sponsors and Collaborators
Montefiore Medical Center
  More Information

No publications provided

Responsible Party: Joel Neugarten MD, Montefiore Medical Center
ClinicalTrials.gov Identifier: NCT01392313     History of Changes
Other Study ID Numbers: 10-03-068
Study First Received: July 11, 2011
Last Updated: July 11, 2011
Health Authority: United States: Institutional Review Board
United States: Food and Drug Administration

Keywords provided by Montefiore Medical Center:
carnitine, kidney

Additional relevant MeSH terms:
Carnitine
Growth Substances
Micronutrients
Pharmacologic Actions
Physiological Effects of Drugs
Vitamin B Complex
Vitamins

ClinicalTrials.gov processed this record on October 22, 2014